Trade Summary

4 days ago, 5AM Partners VII, LLC, serving as 10% owner Owner at Skye Bioscience, Inc. (SKYE), sold 375,840 shares at $0.37 per share, for a total transaction value of $140,313.00. Following this transaction, 5AM Partners VII, LLC now holds 7,850,155 shares of SKYE.

This sale represents a 4.57% decrease in 5AM Partners VII, LLC's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, August 18, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, August 20, 2026 at 5:57 PM ET, 2 days after the trade was made.

Skye Bioscience, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.